A tumor board is an approach to treatment planning. It consists of different cancer specialists who review and discuss a patient's medical condition and the possible treatment options. To learn more about tumor boards and their role in cancer treatment, Cancer.Net talked with Anthony F. Provenzano, MD.
As many as 70,000 young adults in their 20s and 30s are diagnosed with cancer each year. Doctors are learning that cancer in young adults is sometimes different than cancer in older adults, and young adults with cancer face a different set of challenges than older and younger people with cancer. Cancer.Net talked with Archie Bleyer, MD, to learn more about young adults with cancer.
More than 30,000 medical professionals from around the world who treat people with cancer will meet later this month in Chicago at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest advances in cancer care, treatment, prevention, and survivorship. As of today, nearly 5,000 studies are available online, and several of these have been highlighted by ASCO. To learn more about the results of these early studies, and what they mean for people with cancer, Cancer.Net talked with Julie Gralow, MD.
It is estimated that more than 62,000 people in the United States this year will be diagnosed with primary melanoma — the most serious type of skin cancer. It is also the sixth most common cancer in men and the seventh most common in women. Cancer.Net talked with John Kirkwood, MD, to learn more about the latest news and research in melanoma and information for survivors.
Erythropoiesis-stimulating agents (ESAs) are medications that help treat anemia caused by chemotherapy. Cancer.Net talked with Alan Lichtin, MD, to learn more about these drugs and what people with cancer should know about them.
Leading experts in genitourinary (GU) cancers met in San Francisco at the first bi-annual Genitourinary Cancers Symposium to present and discuss new research related to prevention, screening, and treatment. GU cancers include cancers of the prostate, kidney, bladder, and testis. Cosponsors of the symposium included the American Society of Clinical Oncology (ASCO), the American Society for Therapeutic Radiology and Oncology (ASTRO), and the Society of Urologic Oncology (SUO). Cancer.Net talked with Howard M. Sandler, MD, MS, to learn more about this meeting and the research presented.
To raise awareness of the dangers of secondhand smoke, the American Society of Clinical Oncology (ASCO) is working with the International Union Against Cancer to promote World Cancer Day on February 4, 2008. The theme is “I love my smoke-free childhood.” Cancer.Net talked with Paul A. Bunn, Jr., MD, to learn more about the dangers of secondhand smoke to children's health, and what parents can do to protect their kids.
A placebo is an inactive drug or treatment in a clinical trial and is often referred to as a “sugar pill.” A placebo-controlled trial compares a new treatment with a placebo; people who receive a placebo are called the control group. The use of placebos in cancer clinical trials is rare. Cancer.Net talked with Richard L. Schilsky, MD, to learn more about the emerging use of placebos in cancer clinical trials.
Leading experts in gastrointestinal (GI) cancers met in Orlando, Florida, to present and discuss new research related to prevention, screening, and treatment. GI cancers include cancers of the esophagus, stomach, pancreas, small bowel, liver, bile duct, colon, and rectum. Held January 25-27, the event is co-sponsored by the American Society of Clinical Oncology (ASCO), American Gastroenterological Association (AGA) Institute, American Society for Therapeutic Radiology and Oncology (ASTRO), and the Society of Surgical Oncology (SSO). Cancer.Net talked with Nicholas Petrelli, MD, to learn more about the recent advances highlighted at this meeting.
More attention is being focused on the differences in the occurrence, frequency, and survival of cancer of different populations in the United States. These populations may include members of minority populations, older adults of any race or background, and those who are poor or geographically isolated. Cancer.Net talked with Derek Raghavan, MD, PhD, to learn more about health disparities in cancer.
